Correlation Between Coya Therapeutics, and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Keros Therapeutics, you can compare the effects of market volatilities on Coya Therapeutics, and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Keros Therapeutics.
Diversification Opportunities for Coya Therapeutics, and Keros Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Coya and Keros is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and Keros Therapeutics
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to under-perform the Keros Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Coya Therapeutics, Common is 1.37 times less risky than Keros Therapeutics. The stock trades about -0.29 of its potential returns per unit of risk. The Keros Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 6,488 in Keros Therapeutics on September 13, 2024 and sell it today you would earn a total of 377.00 from holding Keros Therapeutics or generate 5.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Coya Therapeutics, Common vs. Keros Therapeutics
Performance |
| Timeline |
| Coya Therapeutics, Common |
| Keros Therapeutics |
Coya Therapeutics, and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coya Therapeutics, and Keros Therapeutics
The main advantage of trading using opposite Coya Therapeutics, and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |